RT Journal Article
SR Electronic
T1 Preliminary Study on the Diagnostic Value of Ultrasonic Shear Wave Dispersion for High-risk Esophageal Gastric Varices in Cirrhosis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.11.11.22282074
DO 10.1101/2022.11.11.22282074
A1 Wang, Jiayin
A1 Zhou, Hongyu
A1 Li, Tinghong
A1 Liu, Chuan
A1 Zhao, Lei
A1 Xu, Baiguo
A1 Yin, Weili
A1 Wang, Fang
A1 Liang, Jing
A1 Jing, Xiang
A1 Xiang, Huiling
YR 2022
UL http://medrxiv.org/content/early/2022/11/14/2022.11.11.22282074.abstract
AB Objective To explore the clinical value of two-dimensional ultrasonic shear wave elastography (SWE) and shear wave dispersion (SWD) in the diagnosis of high-risk esophageal gastric varices with cirrhosis.Methods A total of 123 people were included, which were divided into the high-risk esophageal gastric varices (high-risk EGV) group (n =60) and low-risk esophageal gastric varices (low-risk EGV) group (n =63). Both shear wave elastography (SWE) and SWD were adopted to examine each patient’s liver synchronously with the Doppler ultrasonic instrument.Results In total patients, the results of SWD and SWE of the high-risk EGV group were significantly higher than low-risk EGV group respectively. According to SWD examination, the area under the curve (AUC) of high-risk EGV was 0.709(95%CI:0.616-0.802), the optimal cutoff value was 14.35 m/s/kHz, the sensitivity and specificity was 81.7% and 57.1%, the AUC of high-risk EGV in patients with compensated cirrhosis was 0.786(95%CI:0.656-0.916), the optimal cutoff value was 14.35 m/s/kHz, the sensitivity and specificity was 86.4% and 61.1%, while the AUC of high-risk EGV in patients with decompensated cirrhosis was 0.637(95%CI: 0.494-0.780). According to SWE, the AUC of high-risk EGV in all patients, patients with compensated cirrhosis, and patients with decompensated cirrhosis was 0.606(95%CI: 0.506-0.706), 0.596(95%CI: 0.449-0.743), and 0.579(95%CI: 0.434-0.725), respectively, indicating limited diagnostic value.Conclusion SWD predicted the existence of high-risk EGV in patients with compensated cirrhosis non-invasively and provided a supplementary method to determine whether high-risk EGV exists or not in patients, while SWE had limited diagnostic value.Competing Interest StatementThe authors have declared no competing interest.Funding StatementSponsored by Tianjin Health Project. (No. TJWJ2022XK029）Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Ethics Committee of Tianjin Third Central Hospital (Document No. IRB2019-022-03)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsEGVesophageal gastric varicesSWDshear wave dispersionSWEshear wave elastographyTIPStransjugular intrahepatic portosystemic shuntLDRflocation diameter risk factorAASLDAmerican association for the study of liver diseasesALTalanine aminotransferaseHBVHepatitis BHCVHepatitis CALDalcoholic liver diseaseUGBupper gastrointestinal bleedingASascitesHEHepatic encephalopathyPPVpositive predictive valueNPVnegative predictive valueMRImagnetic resonance imagingTEtransient elastographyHVPGhepatic venous pressure gradient